VIDEO: Trulance improves pain in chronic idiopathic constipation, IBS-C

In this exclusive video, Gregory Sayuk, MD, MPH, from the division of gastroenterology at Washington University School of Medicine in St. Louis discusses his poster from Digestive Disease Week on four randomized trials that explored the efficacy of Trulance in patients with chronic idiopathic constipation and constipation-predominant irritable bowel syndrome.In the trials, researchers randomly assigned patients to receive 3 mg or 6 mg of Trulance (plecanatide, Salix) or placebo for 12 weeks. Patients recorded daily abdominal pain symptoms at baseline, at the end of 12 weeks of treatment andRead More

Share on facebook
Share on twitter
Share on linkedin